環境の変化、急速な都市化、微生物の発生など、さまざまな要因に起因する、抗しがたい病気の蔓延が拡大しています。移植患者は微生物、感染症、微生物、寄生虫によってもたらされるあらゆる種類の汚染にさらされる可能性があるため、移植前には例外的な配慮が受け入れられる必要があります。これらには、インフルエンザ感染汚染、尿路疾患、肺炎球菌性肺炎、サイトメガロウイルス、エプスタイン・バー感染症、ヒトヘルペスウイルス 6 型などが含まれます。さらに、抗菌薬による閉塞の拡大も同様に深刻な懸念の理由であり、抵抗力のない感染症の優勢さをさらに高めています。たとえば、Communities for infection Prevention and Anticipation によると、米国では毎年 280 万件以上の抗菌薬が安全な(antimicrobial-safe)汚染が発生しています。その後、抗えない病気の一般性の拡大により、移植における網羅的な分子診断の実行への関心が高まり、市場を牽引しています。
目次
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030(USD MILLION)
TABLE 3 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR REAGENTS & KITS, BY REGION, 2018-2030(USD MILLION)
TABLE 4 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR INSTRUMENTS, BY REGION, 2018-2030(USD MILLION)
TABLE 5 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR SERVICES & SOFTWARE, BY REGION, 2018-2030(USD MILLION)
TABLE 6 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030(USD MILLION)
TABLE 7 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030(USD MILLION)
TABLE 8 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR SEQUENCING, BY REGION, 2018-2030(USD MILLION)
TABLE 9 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR MICROARRAY, BY REGION, 2018-2030(USD MILLION)
TABLE 10 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR OTHERS, BY REGION, 2018-2030(USD MILLION)
TABLE 11 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030(USD MILLION)
TABLE 12 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION, 2018-2030(USD MILLION)
TABLE 13 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030(USD MILLION)
TABLE 14 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, FOR OTHERS, BY REGION, 2018-2030(USD MILLION)
TABLE 15 GLOBAL: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 16 NORTH AMERICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17 NORTH AMERICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18 NORTH AMERICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19 NORTH AMERICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 20 US MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21 US MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22 US: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 23 CANADA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24 CANADA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25 CANADA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 26 EUROPE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27 EUROPE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28 EUROPE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29 EUROPE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 30 GERMANY MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31 GERMANY: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32 GERMANY: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 33 UK MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34 UK: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35 UK: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 36 FRANCE MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37 FRANCE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38 FRANCE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 39 ITALY: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40 ITALY: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41 ITALY: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 42 SPAIN: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43 SPAIN: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44 SPAIN: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 45 REST OF EUROPE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46 REST OF EUROPE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47 REST OF EUROPE: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 48 ASIA PACIFIC: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49 ASIA PACIFIC: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50 ASIA PACIFIC: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 52 JAPAN: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53 JAPAN: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54 JAPAN: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 55 CHINA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56 CHINA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57 CHINA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 58 INDIA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59 INDIA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60 INDIA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 61 AUSTRALIA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62 AUSTRALIA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63 AUSTRALIA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 64 SOUTH KOREA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65 SOUTH KOREA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66 SOUTH KOREA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 67 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 70 REST OF THE WORLD: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71 REST OF THE WORLD: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72 REST OF THE WORLD: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73 REST OF THE WORLD: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 74 MIDDLE EAST MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75 MIDDLE EAST: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76 MIDDLE EAST: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 77 AFRICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78 AFRICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79 AFRICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 80 LATIN AMERICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81 LATIN AMERICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82 LATIN AMERICA: MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 83 MAJOR PLAYERS IN THE GLOBAL MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET
TABLE 84 MOST ACTIVE PLAYER IN THE GLOBAL MOLECULAR DIAGNOSTICS FOR TRANSPLANT MARKET
TABLE 85 PRODUCT LAUNCH/ PRODUCT APPROVAL
TABLE 86 PARTNERSHIP/AGREEMENT
TABLE 87 MERGER/ACQUISTION
TABLE 88 BIOMÉRIEUX SA: PRODUCT OFFERED
TABLE 89 BIOMÉRIEUX SA: KEY DEVELOPMENTS
TABLE 90 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE OFFERED
TABLE 91 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS
TABLE 92 CEPHEID: PRODUCT/SERVICE OFFERED
TABLE 93 CEPHEID: KEY DEVELOPMENTS
TABLE 94 ALTONA DIAGNOSTICS GMBH: PRODUCTS OFFERED
TABLE 95 ALTONA DIAGNOSTICS GMBH: KEY DEVELOPMENTS
TABLE 96 ELITECHGROUP: PRODUCTS OFFERED
TABLE 97 ELITECHGROUP: KEY DEVELOPMENTS
TABLE 98 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
TABLE 99 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS
TABLE 100 HOLOGIC, INC: PRODUCTS OFFERED
TABLE 101 HOLOGIC INC.: KEY DEVELOPMENTS
TABLE 102 QIAGEN N.V.: PRODUCTS OFFERED
TABLE 103 QIAGEN N.V.: KEY DEVELOPMENTS
TABLE 104 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 105 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS
TABLE 106 ABBOTT: PRODUCTS OFFERED
TABLE 107 ABBOTT: KEY DEVELOPMENTS
